Tianda Pharmaceuticals Ltd (455):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tianda Pharmaceuticals Ltd (455) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11515
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic areas such as cardio-cerebrovascular drugs, pediatric drugs, anti-flu and respiratory drugs, anti-infective drugs, anti-diabetic drugs, anti-neoplastics drugs and detoxification drugs. Its cardio-cerebrovascular drugs comprise zhikang granules, cerebroprotein hydrolysate injection, valsartan capsules, aceglutamide injection, vinpocetine injection and aspirin enteric-coated tablets. Tianda Pharma also conducts research and development for vaccines and blood products. The company operates two research and development centers and production bases in Zhuhai and Kunming, China. It has operations in China and Australia. Tianda Pharma is headquartered in Hong Kong.

Tianda Pharmaceuticals Ltd (455) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tianda Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aslan Pharma Raises Additional USD9 Million in Venture Financing 11
Aslan Pharma Raises USD34 Million in Series C Financing 13
Equity Offering 15
Tianda Pharma to Raise USD14 Million in Private Placement of Shares 15
Acquisition 16
Tianda Pharma Acquires Cynergy Health, Consumr Healthcare Company 16
Tianda Pharmaceuticals Ltd – Key Competitors 17
Tianda Pharmaceuticals Ltd – Key Employees 18
Tianda Pharmaceuticals Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Jun 28, 2018: Tianda Pharmaceuticals: Annual Results Announcement for the Year Ended 31 March 2018 20
Nov 22, 2017: Tianda Pharmaceuticals: Interim Results For The Six Months Ended 30 September 2017 23
Corporate Communications 25
Dec 29, 2017: Tianda Pharmaceuticals Announces Resignation of non-executive director 25
Dec 27, 2017: Tianda Pharmaceuticals Announces Appointment of Non-executive Director 26
Jan 25, 2017: Tianda Pharmaceuticals: Change of Managing Director and Re-Designation of Director 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tianda Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Tianda Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aslan Pharma Raises Additional USD9 Million in Venture Financing 11
Aslan Pharma Raises USD34 Million in Series C Financing 13
Tianda Pharma to Raise USD14 Million in Private Placement of Shares 15
Tianda Pharma Acquires Cynergy Health, Consumr Healthcare Company 16
Tianda Pharmaceuticals Ltd, Key Competitors 17
Tianda Pharmaceuticals Ltd, Key Employees 18
Tianda Pharmaceuticals Ltd, Other Locations 19

List of Figures
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tianda Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tianda Pharmaceuticals Ltd (455):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nisshinbo Holdings, Inc.:企業の戦略・SWOT・財務情報
    Nisshinbo Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nisshinbo Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Stamps.com Inc. (STMP):企業の財務・戦略的SWOT分析
    Stamps.com Inc. (STMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Mauritius Commercial Bank Limited:企業の戦略・SWOT・財務分析
    The Mauritius Commercial Bank Limited - Strategy, SWOT and Corporate Finance Report Summary The Mauritius Commercial Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Laboratoires Pierre Fabre SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs …
  • SCC Soft Computer:企業の戦略的SWOT分析
    SCC Soft Computer - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Cannabics Pharmaceuticals Inc (CNBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated cellular imaging and analysis platform designed …
  • Bollore SA (BOL):企業の財務・戦略的SWOT分析
    Bollore SA (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BASF SE:企業の戦略・SWOT・財務情報
    BASF SE - Strategy, SWOT and Corporate Finance Report Summary BASF SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Western Areas Limited:企業の戦略・SWOT・財務情報
    Western Areas Limited - Strategy, SWOT and Corporate Finance Report Summary Western Areas Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Expro Holdings UK 3 Ltd:企業の戦略的SWOT分析
    Expro Holdings UK 3 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Jardine Lloyd Thompson Group plc:企業の戦略・SWOT・財務分析
    Jardine Lloyd Thompson Group plc - Strategy, SWOT and Corporate Finance Report Summary Jardine Lloyd Thompson Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Texas Instruments Incorporated:企業の戦略・SWOT・財務情報
    Texas Instruments Incorporated - Strategy, SWOT and Corporate Finance Report Summary Texas Instruments Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Japan Oil, Gas and Metals National Corp:企業の戦略的SWOT分析
    Japan Oil, Gas and Metals National Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Haworth Inc:企業の戦略的SWOT分析
    Haworth Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Fuerst Day Lawson Ltd:企業の戦略・SWOT・財務情報
    Fuerst Day Lawson Ltd - Strategy, SWOT and Corporate Finance Report Summary Fuerst Day Lawson Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly Isotechnika Pharma Inc, is a clinical stage biopharmaceutical company which develops and commercializes therapies for the treatment of diseases with high unmet medical need. Its pipeline products include Voclosporin, is an inves …
  • Apetit Oyj:企業の戦略・SWOT・財務情報
    Apetit Oyj - Strategy, SWOT and Corporate Finance Report Summary Apetit Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Dexcel PT Israel Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Dexcel PT Israel Ltd (Dexcel Pharma), a subsidiary of Dexcel PT Holdings Ltd, develops, manufactures and markets branded and generic pharmaceuticals. Its featured products include PerioChip (chlorhexidine gluconate), a non-antibiotic adjunct treatment for scaling and root planing and adult p …
  • Applied Industrial Technologies, Inc.:企業の戦略・SWOT・財務分析
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Yanmar Co Ltd:企業の戦略的SWOT分析
    Yanmar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆